Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Nuwellis, Inc. (NUWE)

2.75   0.1 (3.77%) 06-01 15:59
Open: 2.66 Pre. Close: 2.65
High: 2.8999 Low: 2.5711
Volume: 41,613 Market Cap: 3(M)

Technical analysis

as of: 2023-06-01 4:45:53 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.27     One year: 6.69
Support: Support1: 2.55    Support2: 2.12
Resistance: Resistance1: 4.51    Resistance2: 5.73
Pivot: 2.9
Moving Average: MA(5): 2.84     MA(20): 3.16
MA(100): 5.71     MA(250): 29.68
MACD: MACD(12,26): -0.5     Signal(9): -0.5
Stochastic oscillator: %K(14,3): 16     %D(3): 14.1
RSI: RSI(14): 34.1
52-week: High: 185  Low: 2.55
Average Vol(K): 3-Month: 83 (K)  10-Days: 69 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ NUWE ] has closed above bottom band by 21.4%. Bollinger Bands are 79.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.9 - 2.92 2.92 - 2.94
Low: 2.53 - 2.55 2.55 - 2.57
Close: 2.72 - 2.75 2.75 - 2.78

Company Description

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Headline News

Tue, 23 May 2023
Nuwellis, Inc. Reports Inducem - GuruFocus.com

Tue, 16 May 2023
Is Nuwellis Inc (NUWE) Stock a Good Value Tuesday? - InvestorsObserver

Tue, 09 May 2023
Healthcare Stocks Moving Tuesday: LGVN, VYGR, YMAB, NVAX, TRVN, ENTA, CHRS, NUWE - InvestorsObserver

Tue, 09 May 2023
Nuwellis, Inc. Announces First Quarter 2023 Financial Results - Yahoo Finance

Tue, 18 Apr 2023
Nuwellis, Inc. To Announce First Quarter 2023 Financial Results on May 9, 2023 - Yahoo Finance

Mon, 17 Apr 2023
Does Nuwellis Inc (NUWE) Have What it Takes to be in Your Portfolio Monday? - InvestorsObserver

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 1 (M)
Shares Float 0 (M)
% Held by Insiders 0.4 (%)
% Held by Institutions 1.7 (%)
Shares Short 33 (K)
Shares Short P.Month 31 (K)

Stock Financials

EPS -48.6
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 23.04
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 3.92
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -0.06
PEG Ratio 0
Price to Book value 0.11
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.